rs6837293 — PRKG2

PRKG2 rs6837293 — A Tentative Gout-Susceptibility Signal in a Key Inflammatory Kinase

When a gout attack strikes, the pain is driven not just by uric acid crystals lodging in a joint — it's driven by the inflammatory cascade those crystals ignite. PRKG2 encodes cGMP-dependent protein kinase II (cGKII)¹¹ cGMP-dependent protein kinase II (cGKII)
a serine/threonine kinase activated by cyclic GMP, expressed in intestinal epithelium, kidney, cartilage, and immune cells, a signaling enzyme that turns out to sit at a key amplification point in this cascade. The intronic variant rs6837293 was identified as a possible gout-susceptibility locus in a Taiwanese genome-wide analysis — but replication has been elusive, leaving its clinical significance unsettled.

The Mechanism

cGKII phosphorylates the CFTR chloride channel in intestinal epithelium, regulates renin secretion in the kidney, and supports endochondral bone growth — but its most relevant role for gout is in immune cells. A 2015 study by Zhou et al.²² A 2015 study by Zhou et al.
Zhou et al. Cyclic GMP-dependent protein kinase II is necessary for macrophage M1 polarization and phagocytosis via toll-like receptor 2. J Mol Med, 2015 demonstrated that cGKII expression is high in M1-polarized macrophages (the pro-inflammatory phenotype) but low in M2 (anti-inflammatory) macrophages. When scientists silenced cGKII, M1 activation was significantly reduced. Critically, when macrophages were exposed to monosodium urate (MSU) crystals — the trigger of gout attacks — cGKII and toll-like receptor 2 (TLR2) expression both increased, amplifying M1 polarization and phagocytic activity. Knocking down cGKII blunted the MSU-induced inflammatory response.

This positions PRKG2 as an inflammation amplifier in gout: variants that alter cGKII expression or activity could modulate how intensely the innate immune system responds to urate crystals. The intronic location of rs6837293 suggests a regulatory rather than coding mechanism — potentially affecting PRKG2 expression levels in relevant tissues.

The Evidence

Initial discovery — Taiwanese population: Chang et al. 2009³³ Chang et al. 2009
Chang SJ et al. The cyclic GMP-dependent protein kinase II gene associates with gout disease: identified by genome-wide analysis and case-control study. Ann Rheum Dis, 2009 identified PRKG2 through a genome-wide analysis in 8 gout patients and 10 unaffected relatives, then validated in a case-control study of 74 male gout patients and 74 age-matched healthy controls from a Taiwanese population. Both rs6837293 and rs7688672 showed significant association with gout under a recessive model (rs6837293 OR = 2.72, 95% CI 1.13–6.54; rs7688672 OR = 2.89, 95% CI 1.19–7.02), and the association remained after adjusting for serum uric acid levels — suggesting that PRKG2 may influence gout risk through the inflammatory response to crystals rather than through urate concentration alone.

Replication failure — Japanese population: Sakiyama et al. 2014⁴⁴ Sakiyama et al. 2014
Sakiyama M et al. Common variants of cGKII/PRKG2 are not associated with gout susceptibility. J Rheumatol, 2014 attempted replication in a substantially larger Japanese cohort: 741 male gout patients and 1,302 controls. All four PRKG2 variants — including rs6837293 — showed no association with gout in any genetic model (allele frequency, dominant, or recessive). The authors concluded that cGKII is not involved in gout susceptibility.

Mixed results — Chinese cohort: Guo et al. 2015⁵⁵ Guo et al. 2015
Guo M et al. Polymorphism of rs7688672 and rs10033237 in cGKII/PRKG2 and gout susceptibility of Han population in northern China. Gene, 2015 tested different PRKG2 variants in 405 gout cases and 429 controls (Han Chinese), finding rs10033237 associated with gout but rs7688672 not — further highlighting the inconsistency of PRKG2 findings across populations and variant sets.

Taken together, the evidence for rs6837293 is emerging at best. The original study was small (74 cases), and the larger replication failed. The biological mechanism — cGKII amplifying urate crystal inflammation — is plausible and supported by in vitro data, but the specific role of this intronic variant remains unestablished.

Practical Actions

For TT homozygotes, the empirical gout-susceptibility signal (even if fragile) points toward the inflammatory arm of gout rather than the urate-production arm. This means standard urate-lowering dietary measures are still relevant but may need to be paired with attention to foods and supplements that modulate innate immune activation.

Limiting dietary purines (organ meats, shellfish, red meat, alcohol — especially beer and spirits) reduces urate substrate and therefore crystal formation risk regardless of PRKG2 genotype. If cGKII does amplify the inflammatory response to existing crystals, maintaining serum urate well below the crystallisation threshold of 6.8 mg/dL becomes more important for TT carriers than for CC carriers.

Serum uric acid monitoring is the most actionable next step — a fasting uric acid test can stratify actual hyperuricemia risk, which is the prerequisite for crystal formation regardless of downstream inflammatory gene variants.

Interactions

With SLC2A9 rs3733591 and ABCG2 rs2231142: SLC2A9 and ABCG2 are the strongest determinants of serum urate concentration (explaining ~5% of variance each). PRKG2, if genuinely involved in gout susceptibility, would represent a downstream effector operating after crystal formation — meaning the combination of high-urate genotypes (SLC2A9 C/C, ABCG2 T/T) plus the proposed PRKG2 rs6837293 TT genotype might confer both elevated crystal burden and an amplified inflammatory response, though no study has examined this combination directly.

With rs7688672 (PRKG2): The original Taiwanese study found both rs6837293 and rs7688672 associated with gout under a recessive model. These two intronic PRKG2 variants may be in linkage disequilibrium and tag the same underlying functional signal. Carriers of TT at both loci may represent the subgroup with the most consistent PRKG2-related risk signal.